Early antibody treatment, inflammation, and risk of post-COVID conditions

Post-COVID conditions (PCCs) are common and have significant morbidity. Risk factors for PCC include advancing age, female sex, obesity, and diabetes mellitus. Little is known about treatment, inflammation, and PCC. Among 882 individuals with confirmed SARS-CoV-2 infection participating in a randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebo, Kelly A., Heath, Sonya L., Fukuta, Yuriko, Zhu, Xianming, Baksh, Sheriza, Abraham, Allison G., Habtehyimer, Feben, Shade, David, Ruff, Jessica, Ram, Malathi, Laeyendecker, Oliver, Fernandez, Reinaldo E., Patel, Eshan U., Baker, Owen R., Shoham, Shmuel, Cachay, Edward R., Currier, Judith S., Gerber, Jonathan M., Meisenberg, Barry, Forthal, Donald N., Hammitt, Laura L., Huaman, Moises A., Levine, Adam, Mosnaim, Giselle S., Patel, Bela, Paxton, James H., Raval, Jay S., Sutcliffe, Catherine G., Anjan, Shweta, Gniadek, Thomas, Kassaye, Seble, Blair, Janis E., Lane, Karen, McBee, Nichol A., Gawad, Amy L., Das, Piyali, Klein, Sabra L., Pekosz, Andrew, Bloch, Evan M., Hanley, Daniel, Casadevall, Arturo, Tobian, Aaron A. R., Sullivan, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653913/
https://www.ncbi.nlm.nih.gov/pubmed/37724870
http://dx.doi.org/10.1128/mbio.00618-23

Ejemplares similares

Ejemplares similares